Stifel Nicolaus Issues Pessimistic Forecast for Tempus AI (NASDAQ:TEM) Stock Price

Tempus AI (NASDAQ:TEM) had its price objective cut by investment analysts at Stifel Nicolaus from $60.00 to $50.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage currently has a “hold” rating on the stock. Stifel Nicolaus’ price objective points to a potential upside of 13.97% from the company’s previous close.

Other equities research analysts also recently issued research reports about the company. Guggenheim raised their price target on Tempus AI from $60.00 to $65.00 and gave the company a “buy” rating in a report on Thursday, July 16th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Tempus AI in a research note on Wednesday, June 17th. Lake Street Capital cut shares of Tempus AI to a “hold” rating in a report on Monday, July 20th. Freedom Capital upgraded Tempus AI to a “hold” rating in a report on Tuesday, June 30th. Finally, Needham & Company LLC restated a “buy” rating and issued a $75.00 price target on shares of Tempus AI in a research note on Friday. Nine equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $68.15.

Tempus AI Price Performance

NASDAQ:TEM opened at $43.87 on Monday. The company has a quick ratio of 3.16, a current ratio of 3.30 and a debt-to-equity ratio of 3.06. The stock’s 50 day moving average price is $51.40 and its two-hundred day moving average price is $52.59. The firm has a market capitalization of $7.88 billion, a price-to-earnings ratio of -30.47 and a beta of 3.58. Tempus AI has a 12-month low of $40.77 and a 12-month high of $104.32.

Tempus AI (NASDAQ:TEM) last issued its earnings results on Thursday, July 30th. The company reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.14) by $0.10. The company had revenue of $382.49 million during the quarter, compared to the consensus estimate of $379.69 million. Tempus AI had a negative return on equity of 50.28% and a negative net margin of 17.77%.The firm’s revenue for the quarter was up 21.6% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.22) EPS. On average, analysts anticipate that Tempus AI will post -1.35 earnings per share for the current year.

Insider Activity

In other Tempus AI news, EVP Andrew Polovin sold 8,703 shares of the company’s stock in a transaction on Tuesday, May 19th. The stock was sold at an average price of $44.07, for a total transaction of $383,541.21. Following the completion of the sale, the executive vice president directly owned 128,215 shares in the company, valued at $5,650,435.05. This represents a 6.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Eric P. Lefkofsky sold 250,000 shares of the firm’s stock in a transaction on Tuesday, July 28th. The shares were sold at an average price of $42.06, for a total value of $10,515,000.00. Following the completion of the sale, the chief executive officer directly owned 200,000 shares in the company, valued at approximately $8,412,000. This represents a 55.56% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 699,793 shares of company stock valued at $33,763,231 in the last three months. Company insiders own 24.26% of the company’s stock.

Institutional Trading of Tempus AI

Several large investors have recently bought and sold shares of the business. Victory Capital Management Inc. grew its position in Tempus AI by 1.5% in the third quarter. Victory Capital Management Inc. now owns 11,078 shares of the company’s stock valued at $894,000 after acquiring an additional 162 shares during the last quarter. Legacy Bridge LLC grew its stake in shares of Tempus AI by 1.6% during the fourth quarter. Legacy Bridge LLC now owns 12,418 shares of the company’s stock worth $733,000 after buying an additional 193 shares during the last quarter. Truist Financial Corp increased its holdings in shares of Tempus AI by 5.8% during the fourth quarter. Truist Financial Corp now owns 3,532 shares of the company’s stock worth $209,000 after buying an additional 194 shares in the last quarter. Farther Finance Advisors LLC lifted its stake in shares of Tempus AI by 3.5% in the 4th quarter. Farther Finance Advisors LLC now owns 6,390 shares of the company’s stock valued at $377,000 after acquiring an additional 219 shares during the last quarter. Finally, SeaCrest Wealth Management LLC grew its position in Tempus AI by 3.7% during the 3rd quarter. SeaCrest Wealth Management LLC now owns 6,488 shares of the company’s stock worth $524,000 after acquiring an additional 229 shares during the last quarter. 24.22% of the stock is owned by institutional investors and hedge funds.

About Tempus AI

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.